Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01871857 · ClinicalTrials.gov registry record · Phase 4
7% Hypertonic Saline for Acute Bronchiolitis
A Phase 4 study, sponsored by Le Bonheur Children's Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 101
- Enrollment target
NCT01871857 is a Phase 4 study that has completed, run by Le Bonheur Children's Hospital. The registered enrollment target is 101 participants.
The verdict
NCT01871857, a Phase 4 study, has completed, sponsored by Le Bonheur Children's Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 101 participants
- Enrollment target
Study Summary
Research suggests that hypertonic saline may improve mucous flow in infants with acute bronchiolitis. Data suggest a trend favoring reduced length of hospital stay and improved pulmonary scores with increasing concentration of nebulized solution to 3% and 5% saline as compared to 0.9% saline mixed with epinephrine. To our knowledge, 7% hypertonic saline has not been previously investigated. OUr hypothesis was that 7% hypertonic saline would improve bronchiolitis severity scores and admission rate.
Interventions
- DRUG Hypertonic saline and epinephrine
- DRUG Normal saline and epinephrine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2010-11 |
| Est. Completion | 2012-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01871857
The ClinicalTrials.gov registry entry for NCT01871857 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Le Bonheur Children's Hospital, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Hypertonic saline and epinephrine is the first listed.
NCT01871857 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01871857 about?
NCT01871857 is a clinical study titled "7% Hypertonic Saline for Acute Bronchiolitis". Research suggests that hypertonic saline may improve mucous flow in infants with acute bronchiolitis. Data suggest a trend favoring reduced length of hospital stay and improved pulmonary scores with increasing concentration of nebulized solution to 3% and 5% saline as compared to 0.9% saline mixed w...
What is the current status of trial NCT01871857?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 101 participants. The study started on 2010-11. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01871857?
The interventions under investigation include: Hypertonic saline and epinephrine (DRUG), Normal saline and epinephrine (DRUG).
Who is sponsoring clinical trial NCT01871857?
This trial is sponsored by Le Bonheur Children's Hospital, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.